Matthew D. Gallovic

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways”.

STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways

The Journal of Immunology(2021)10.4049/jimmunol.2001317

N/A

0DataRank · unranked

33 citations

Toru Uchimura, Matthew D. Gallovic, Madhan Thamilarasan, Wei-Chun Chou, Sara A. Gibson +10 more

A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.09.067

N/A

0DataRank · unranked

79 citations

Erik S. Pena, Stephen A. Ehrenzeller, Matthew D. Gallovic, Liubov M. Lifshits, Christopher J. Genito +3 more

STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.05.017

N/A

0DataRank · unranked

29 citations

Robert D. Junkins, Adam Sandor, Erik S. Pena, Christopher Sample, Ariel K. Mason +7 more

Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine

International Journal of Pharmaceutics(2022)10.1016/j.ijpharm.2022.121839

N/A

0DataRank · unranked

16 citations

Matthew D. Gallovic, Jonathan W. Williams, Ted M. Ross, Eric M. Bachelder, Kristy M. Ainslie +1 more